These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37642220)

  • 1. Melatonin suppresses Akt/mTOR/S6K activity, induces cell apoptosis, and synergistically inhibits cell growth with sunitinib in renal carcinoma cells via reversing Warburg effect.
    Xue KH; Jiang YF; Bai JY; Zhang DZ; Chen YH; Ma JB; Zhu ZJ; Wang X; Guo P
    Redox Rep; 2023 Dec; 28(1):2251234. PubMed ID: 37642220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3K-Akt-mTOR inhibition by GNE-477 inhibits renal cell carcinoma cell growth
    Ye X; Ruan JW; Huang H; Huang WP; Zhang Y; Zhang F
    Aging (Albany NY); 2020 May; 12(10):9489-9499. PubMed ID: 32421688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway.
    Liu H; Li X; Duan Y; Xie JB; Piao XL
    J Ethnopharmacol; 2021 May; 271():113907. PubMed ID: 33556477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential new therapy of Rapalink-1, a new generation mammalian target of rapamycin inhibitor, against sunitinib-resistant renal cell carcinoma.
    Kuroshima K; Yoshino H; Okamura S; Tsuruda M; Osako Y; Sakaguchi T; Sugita S; Tatarano S; Nakagawa M; Enokida H
    Cancer Sci; 2020 May; 111(5):1607-1618. PubMed ID: 32232883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells.
    Li H; Jin X; Zhang Z; Xing Y; Kong X
    Cell Biochem Funct; 2013 Jul; 31(5):427-33. PubMed ID: 23086777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN.
    Deng W; Han W; Fan T; Wang X; Cheng Z; Wan B; Chen J
    Biomed Pharmacother; 2018 Nov; 107():1505-1513. PubMed ID: 30257368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sunitinib induces autophagy via suppressing Akt/mTOR pathway in renal cell carcinoma].
    Cao P; Jiang XJ; Xi ZJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):584-589. PubMed ID: 29263493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin inhibits proliferation, migration, and invasion by inducing ROS-mediated apoptosis via suppression of the PI3K/Akt/mTOR signaling pathway in gallbladder cancer cells.
    Chen K; Zhu P; Chen W; Luo K; Shi XJ; Zhai W
    Aging (Albany NY); 2021 Sep; 13(18):22502-22515. PubMed ID: 34580235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 16-Hydroxycleroda-3, 13-dien-15, 16-olide inhibits the proliferation and induces mitochondrial-dependent apoptosis through Akt, mTOR, and MEK-ERK pathways in human renal carcinoma cells.
    Liu C; Lee WC; Huang BM; Chia YC; Chen YC; Chen YC
    Phytomedicine; 2017 Dec; 36():95-107. PubMed ID: 29157834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic value of SC66 in human renal cell carcinoma cells.
    Xu M; Wang Y; Zhou LN; Xu LJ; Jin ZC; Yang DR; Chen MB; Zhu J
    Cell Death Dis; 2020 May; 11(5):353. PubMed ID: 32393791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells.
    D'Amato C; Rosa R; Marciano R; D'Amato V; Formisano L; Nappi L; Raimondo L; Di Mauro C; Servetto A; Fulciniti F; Cipolletta A; Bianco C; Ciardiello F; Veneziani BM; De Placido S; Bianco R
    Br J Cancer; 2014 Sep; 111(6):1168-79. PubMed ID: 25093491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPA/LPAR1 signaling induces PGAM1 expression via AKT/mTOR/HIF-1α pathway and increases aerobic glycolysis, contributing to keratinocyte proliferation.
    Kim D; Khin PP; Lim OK; Jun HS
    Life Sci; 2022 Dec; 311(Pt B):121201. PubMed ID: 36400203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NKAP promotes renal cell carcinoma growth via AKT/mTOR signalling pathway.
    Ma Q; Hou L; Gao X; Yan K
    Cell Biochem Funct; 2020 Jul; 38(5):574-581. PubMed ID: 32032976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin prevents diabetes-associated cognitive dysfunction from microglia-mediated neuroinflammation by activating autophagy via TLR4/Akt/mTOR pathway.
    Cui Y; Yang M; Wang Y; Ren J; Lin P; Cui C; Song J; He Q; Hu H; Wang K; Sun Y
    FASEB J; 2021 Apr; 35(4):e21485. PubMed ID: 33709562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Elemene induces apoptosis in human renal-cell carcinoma 786-0 cells through inhibition of MAPK/ERK and PI3K/Akt/ mTOR signalling pathways.
    Zhan YH; Liu J; Qu XJ; Hou KZ; Wang KF; Liu YP; Wu B
    Asian Pac J Cancer Prev; 2012; 13(6):2739-44. PubMed ID: 22938451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 induces drug resistance in renal cell carcinoma.
    Ishibashi K; Koguchi T; Matsuoka K; Onagi A; Tanji R; Takinami-Honda R; Hoshi S; Onoda M; Kurimura Y; Hata J; Sato Y; Kataoka M; Ogawsa S; Haga N; Kojima Y
    Fukushima J Med Sci; 2018 Dec; 64(3):103-110. PubMed ID: 30369518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT5E inhibition suppresses the growth of sunitinib-resistant cells and EMT course and AKT/GSK-3β signaling pathway in renal cell cancer.
    Peng D; Hu Z; Wei X; Ke X; Shen Y; Zeng X
    IUBMB Life; 2019 Jan; 71(1):113-124. PubMed ID: 30281919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisebromoamide, an extract from Lyngbya species, induces apoptosis through ERK and mTOR inhibitions in renal cancer cells.
    Suzuki K; Mizuno R; Suenaga K; Teruya T; Tanaka N; Kosaka T; Oya M
    Cancer Med; 2013 Feb; 2(1):32-9. PubMed ID: 24133625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benchmarking effects of mTOR, PI3K, and dual PI3K/mTOR inhibitors in hepatocellular and renal cell carcinoma models developing resistance to sunitinib and sorafenib.
    Serova M; de Gramont A; Tijeras-Raballand A; Dos Santos C; Riveiro ME; Slimane K; Faivre S; Raymond E
    Cancer Chemother Pharmacol; 2013 May; 71(5):1297-307. PubMed ID: 23479136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating rational non-cross-resistant combination therapy in advanced clear cell renal cell carcinoma: combined mTOR and AKT inhibitor therapy.
    Holland WS; Tepper CG; Pietri JE; Chinn DC; Gandara DR; Mack PC; Lara PN
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):185-94. PubMed ID: 21644050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.